AC Immune SA (ACIU) has released an update.
AC Immune SA has entered into an agreement with Jefferies LLC to sell up to $80.0 million of its common shares from time to time on the open market. The new sales agreement replaces a previous one from 2021, and AC Immune SA will set a minimum floor price for the shares, subject to adjustments. This arrangement allows the company to incrementally raise capital, potentially strengthening its financial position and investment appeal.
For further insights into ACIU stock, check out TipRanks’ Stock Analysis page.
